Capha Pharmaceuticals Inc.

OOTC:FPSUFOTC Markets

- -

USD

- -

OTC:FPSUF

(OTC Markets)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 10/23

Stock

S&P 500

- -

14.20

- -

81.12

- -

68.34

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Revenue per Share
-0.08	-0.27	-0.59	-0.03	-0.04	-0.02	- -	-0.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	Basic EPS, GAAP
-0.06	-0.06	-0.18	-0.03	-0.02	-0.02	-0.03	-0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	Free Cash Flow per Basic Share
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
-0.92	-1.16	-1.42	-1.25	-1.07	-0.54	-0.25	-0.27	-0.08	-0.06	-0.06	-0.06	-0.06	-0.06	-0.07	-0.07	-0.07	Book Value per Share
0.42	0.36	0.01	0.02	0.01	0.01	0.01	- -	-0.01	- -	- -	- -	-0.01	-0.01	-0.01	-0.01	-0.01	Tangible Book Value per Share
6	6	9	10	13	30	55	54	54	64	64	64	64	64	64	64	64	Basic Weighted Avg Shares
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Sales/Revenue/Turnover
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Operating Margin (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Depreciation Expense
- -	-2	-5	- -	- -	-1	- -	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	Net Income, GAAP
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Effective Tax Rate (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Profit Margin (%)
1	2	- -	- -	- -	- -	1	- -	-1	- -	- -	- -	- -	- -	-1	-1	-1	Working Capital
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	LT Debt
3	2	- -	- -	- -	- -	1	- -	-1	- -	- -	- -	- -	- -	- -	-1	-1	Total Equity
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Capital (%)
- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Capital Structure

CAD

•

in mil. unless spec.

	Dec'24	Mar'25	Jun'25
ST Debt	1	1	1
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	64	64	64
Market Capitalization	- -	- -	- -

Working Capital

CAD

•

in mil. unless spec.

	Dec'24	Mar'25	Jun'25
Total Current Assets	- -	- -	- -
Cash, Cash Equivalents & STI	- -	- -	- -
Accounts Receivable, Net	- -	- -	- -
Inventories	- -	- -	- -
Total Current Liabilities	1	1	1
Payables & Accruals	- -	- -	- -
ST Debt	1	1	1
Deferred Revenue	- -	- -	- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Total Equity	33.73%	20.36%	14.16%
Free Cash Flow	-3.68%	10.91%	-3.19%
Net Income, GAAP	-97.26%	-2.13%	-1.73%
Sales/Revenue/Turnover	- -	- -	- -
Total Cash Common Dividend	- -	- -	- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year	Q1	Q2	Q3	Q4	FY
2023	- -	- -	- -	- -	- -
2024	- -	- -	- -	- -	- -
2025	- -	- -	- -	- -	- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year	Q1	Q2	Q3	Q4	FY
2023	- -	- -	- -	- -	- -
2024	- -	- -	- -	- -	- -
2025	- -	- -	- -	- -	- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year	Q1	Q2	Q3	Q4	FY
2023	- -	- -	- -	- -	- -
2024	- -	- -	- -	- -	- -
2025	- -	- -	- -	- -	- -

Similar Companies
Business

Unlock non-US companies

Already premium?

Capha Pharmaceuticals Inc.

Capital Structure

Working Capital

Growth Rates

(avg. rate of change)

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Unlock non-US companies

Unlock non-US companies